Advertisement
Original Articles| Volume 46, ISSUE 6, P740-749, September 15, 1999

Clinical and neurobiological correlates of D10S1423 genotype in Alzheimer’s disease

  • George S Zubenko
    Correspondence
    Address reprint requests to George S. Zubenko, MD, PhD, Western Psychiatric Institute and Clinic, Room E-1230, 3811 O’Hara Street, Pittsburgh, PA 15213
    Affiliations
    Department of Psychiatry, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA (GSZ, HBH, JSS)

    Department of Biological Sciences, Mellon College of Science, Carnegie-Mellon University, Pittsburgh, Pennsylvania, USA (GSZ)
    Search for articles by this author
  • Hugh B Hughes III
    Affiliations
    Department of Psychiatry, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA (GSZ, HBH, JSS)
    Search for articles by this author
  • J.Scott Stiffler
    Affiliations
    Department of Psychiatry, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA (GSZ, HBH, JSS)
    Search for articles by this author

      Abstract

      Background: In a previous genome survey, we detected associations of alleles at six microsatellite loci with typical-onset AD, including the 234bp allele of the D10S1423 locus. The goal of the current study was to explore the clinical, neuropathological, and neurochemical correlates of the D10S1423 234bp allele in a group of 50 autopsy-confirmed cases of Alzheimer’s disease (AD) who lacked other brain diseases.
      Methods: Clinical assessments were performed as part of a longitudinal study of AD and related disorders. Autopsies were performed using standardized methods and diagnoses were made according to established criteria. Genotyping, morphometry, and neurochemical analyses were performed using postmortem brain tissue.
      Results: Patients with AD who carried the D10S1423 234bp allele manifested substantial reductions in dopamine levels in all six cortical regions examined. In contrast, carriers tended to have higher concentrations of cortical norepinephrine and revealed a dosage effect of the D10S1423 234bp allele.
      Conclusions: These findings support the results of our genome survey and suggest that a novel susceptibility gene for AD resides near the D10S1423 locus. The characterization of biologically meaningful subtypes, including genotypic subtypes with particular neurobiological derangements, may be important for the advancement of experimental therapeutics in AD.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Alafuzoff I.
        • Iqbal K.
        • Friden H.
        • Adolfsson R.
        • Winblad B.
        Histopathological criteria for progressive dementia disorders.
        Acta Neuropathol. 1987; 74: 209-225
        • Alzheimer’s Disease Collaborative Group
        The structure of the presenilin 1 (S182) gene and identification of six novel mutations in early onset AD families.
        Nature Genet. 1995; 11: 219-222
        • Bachman D.L.
        • Wolf P.A.
        • Linn R.
        • Konefel J.E.
        • Cobb J.
        • Belanger A.
        • et al.
        Prevalence of dementia and probable senile dementia of the Alzheimer type in the Framingham Study.
        Neurology. 1992; 42: 115-119
        • Bendotti C.
        • Forloni G.
        • Morgan R.
        • O’Hara B.F.
        • Oster-Granite L.
        • Reeves R.H.
        • et al.
        Neuroanatomical localization and quantification of amyloid precursor protein mRNA by in situ hybridization in the brains of normal, aneuploid and lesioned mice.
        Proc Natl Acad Sci USA. 1988; 85: 3628-3632
        • Blacker D.
        • Wilcox M.A.
        • Laird N.M.
        • Rodes L.
        • Horvath S.M.
        • Go R.C.P.
        • et al.
        Alpha-2-macroglobulin is genetically associated with Alzheimer’s disease.
        Nature Genet. 1998; 119: 357-360
        • Boller F.
        • Lopez O.L.
        • Moossy J.
        Diagnosis of dementia.
        Neurology. 1989; 39: 76-79
        • Brion S.
        • Plas J.
        • Jeanneau A.
        La maladie de Pick. Point de vue anatomo-clinique.
        Rev Neurol. 1991; 147: 693-704
        • Campion D.
        • Flaman J.-M.
        • Brice A.
        • Hennequin D.
        • Dubois B.
        • Martin C.
        • et al.
        Mutations of the presenilin 1 gene in families with early-onset Alzheimer’s disease.
        Hum Mol Genet. 1995; 4: 2373-2377
        • Chakravarti A.
        • Slaugenhaupt S.
        • Zubenko G.S.
        Inheritance pattern of platelet membrane fluidity in Alzheimer’s disease.
        Am J Hum Genet. 1989; 44: 799-805
        • Chan-Palay V.
        Depression and senile dementia of the Alzheimer type.
        Dementia. 1990; 1: 253-261
        • Chartier-Harlin M.-C.
        • Crawford F.
        • Houlden H.
        • Warren A.
        • Hughes D.
        • Fidani L.
        • et al.
        Early-onset Alzheimer’s disease caused by mutations at codon 717 of the β-amyloid precursor protein gene.
        Nature. 1991; 353: 844-846
        • Chartier-Harlin M.-C.
        • Parfitt M.
        • Legrain S.
        • Perez-Tur J.
        • Brousseau T.
        • Evans A.
        • et al.
        Apolipoprotein E, ϵ4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer’s disease.
        Hum Mol Genet. 1994; 3: 569-574
        • Chen X.
        • Xia Y.
        • Alford M.
        • DeTeresa R.
        • Hansen L.
        • Klauber M.R.
        • et al.
        The CYP2D6B allele is associated with a milder synaptic pathology in Alzheimer’s disease.
        Ann Neurol. 1995; 38: 653-658
        • Corder E.H.
        • Saunders A.M.
        • Risch N.J.
        • Strittmatter W.J.
        • Schmechel D.E.
        • Gaskell Jr, P.C.
        • et al.
        Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer’s disease.
        Nature Genet. 1994; 7: 180-184
        • Corder E.H.
        • Saunders A.M.
        • Strittmatter W.J.
        • Schmechel D.E.
        • Gaskell P.C.
        • Small G.W.
        • et al.
        Gene dose of apolipoprotein E type-4 allele and the risk of Alzheimer’s disease in late onset families.
        Science. 1993; 261: 921-923
        • Cruts M.
        • Backhovens H.
        • Wang Y.
        • Gassen G.V.
        • Theuns J.
        • DeJonghe C.
        • et al.
        Molecular genetic analysis of familial early-onset Alzheimer’s disease linked to chromosome 14q24.3.
        Hum Mol Genet. 1995; 4: 2363-2371
        • Dai X.Y.
        • Nanko S.
        • Hattori M.
        • Fukuda R.
        • Nagata K.
        • Isse K.
        • et al.
        Association of apolipoprotein E4 with sporadic Alzheimer’s disease is more pronounced in early onset type.
        Neurosci Lett. 1994; 175: 74-76
        • Daniel S.E.
        • Lees A.J.
        Parkinson’s Disease Society Brain Bank, London.
        J Neural Transm. 1993; 39: 165-172
        • Davis R.E.
        • Miller S.
        • Herrnstadt C.
        • Ghosh S.S.
        • Fahy E.
        • Shinobu L.A.
        • et al.
        Mutations in mitochondrial cytochrome c oxidase genes segregate with late-onset Alzheimer disease.
        Proc Natl Acad Sci USA. 1997; 94: 4526-4531
        • Dickson D.W.
        • Crystal H.
        • Mattiace L.A.
        • Kress Y.
        • Schwagerl A.
        • Ksiezak-Reding H.
        • et al.
        Diffuse Lewy body disease.
        Acta Neuropathol. 1989; 78: 572-584
        • Ditter S.M.
        • Mirra S.S.
        Neuropathologic and clinical features of Parkinson’s disease in Alzheimer’s disease patients.
        Neurology. 1987; 37: 754-760
        • Evans D.A.
        • Funkenstein H.H.
        • Albert M.S.
        • Scherr P.A.
        • Cook N.R.
        • Chown M.J.
        • et al.
        Prevalence of Alzheimer’s disease in a community population of older persons.
        JAMA. 1989; 262: 2551-2556
        • Faraone S.V.
        • Matise T.
        • Svrakic D.
        • Pepple J.
        • Malaspina D.
        • Suarez B.
        • et al.
        Genome scan of European American schizophrenia pedigrees.
        Am J Med Genet (Neuropsychiatr Genet). 1998; 81: 290-295
        • Fonnum F.
        Radiochemical microassays for the determination of choline acetyltransferase and acetylcholinesterase activity.
        Biochem J. 1969; 115: 465-472
        • Förstl H.
        • Burns A.
        • Levy R.
        • Cairns N.
        • Luthert P.
        • Lantos P.
        Neurologic signs in Alzheimer’s disease. Results of a prospective clinical and neuropathologic study.
        Arch Neurol. 1992; 49: 1038-1042
        • Förstl H.
        • Burns A.
        • Luthert P.
        • Cairns N.
        • Levy R.
        The Lewy-body variant of Alzheimer’s disease.
        Brit J Psych. 1993; 162: 385-392
      1. GDB Human Genome Database [database on-line]. Baltimore (Maryland, USA): Johns Hopkins University, 1990. Updated daily. Available from Internet: URL http://www.gdb.org/ [cited 4 Sept 1998a; GDB node: USA, http://www.gdb.org/] Mapview display of GDB maps: GDB Comprehensive Map—Chr. 10.

      2. GDB Human Genome Database [database online]. Baltimore (Maryland, USA): Johns Hopkins University, 1990. Updated daily. Available from Internet: URL http://www.gdb.org/ [cited 16 Sept 1998b; GDB node: USA, http://www.gdb.org/] GDB Data Type: Amplimer; Object name: CHLC.GATA70E11.P18111; GDB: 685545.

        • Goate A.M.
        • Chartier-Harlin M.-C.
        • Mullan M.
        • Brown J.
        • Crawford F.
        • Fidani L.
        • et al.
        Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer’s disease.
        Nature. 1991; 349: 704-706
        • Hansen L.
        • Salmon D.
        • Galasko D.
        • Masliah E.
        • Katzman R.
        • DeTeresa R.
        • et al.
        The Lewy body variant of Alzheimer’s disease.
        Neurology. 1990; 40: 1-8
        • Hendrie H.C.
        • Hall K.S.
        • Hui S.
        • Unverzagt F.W.
        • Yu C.E.
        • Lahiri D.K.
        • et al.
        Apolipoprotein E genotypes and Alzheimer’s disease in a community study of elderly African Americans.
        Ann Neurol. 1995; 37: 118-120
        • Hixson J.E.
        • Vernier D.T.
        Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI.
        J Lipid Res. 1990; 31: 545-548
        • Holland A.J.
        Down’s syndrome and dementia of the Alzheimer type.
        in: Burns A. Levy R. Dementia. Chapman and Hall, London1994: 695-708
        • Holmes C.
        • Russ C.
        • Kirov G.
        • Aitchison K.J.
        • Powell J.F.
        • Collier D.A.
        • Lovestone S.
        Apolipoprotein E.
        Biol Psychiatry. 1998; 43: 159-164
        • Joachim C.L.
        • Morris J.H.
        • Selkoe D.J.
        Clinically diagnosed Alzheimer’s disease.
        Ann Neurol. 1988; 24: 50-56
        • Jorm A.F.
        • Korten A.E.
        • Henderson A.S.
        The prevalence of dementia.
        Acta Psychiatr Scand. 1987; 76: 465-479
        • Khachaturian Z.S.
        Diagnosis of Alzheimer’s disease.
        Arch Neurol. 1985; 42: 1097-1105
        • Kimura S.
        • Umeno M.
        • Skoda R.C.
        • Meyer U.A.
        • Gonzalez F.J.
        The human debrisoquine 4-hydroxlyase (CYP2D) locus.
        Am J Hum Genet. 1989; 45: 889-904
        • Langlais P.J.
        • Thal L.
        • Hansen L.
        • Galasko D.
        • Alford M.
        • Masliah E.
        Neurotransmitters in basal ganglia and cortex of Alzheimer’s disease with and without Lewy bodies.
        Neurol. 1993; 43: 1927-1934
        • Leverenz J.
        • Sumi S.M.
        Parkinson’s disease in patients with Alzheimer’s disease.
        Arch Neurol. 1986; 43: 662-664
        • Levy-Lahad E.
        • Wasco W.
        • Poorkaj P.
        • Romano D.M.
        • Oshima J.
        • Pettingell W.H.
        • et al.
        Candidate gene for the chromosome 1 familial Alzheimer’s disease locus.
        Science. 1995; 269: 973-977
        • Levy-Lahad E.
        • Wijsman E.M.
        • Nemens E.
        • Anderson L.
        • Goddard K.A.B.
        • Weber J.L.
        • et al.
        A familial Alzheimer’s disease locus on chromosome 1.
        Science. 1995; 269: 970-973
        • Lippa C.F.
        • Smith T.W.
        • Swearer J.M.
        Alzheimer’s disease and Lewy body disease.
        Ann Neurol. 1994; 35: 81-88
        • Maestre G.
        • Ottman R.
        • Stern Y.
        • Gurland B.
        • Chun M.
        • Tang M.X.
        • et al.
        Apolipoprotein E and Alzheimer’s disease.
        Ann Neurol. 1995; 37: 254-259
        • McKeith I.G.
        • Perry R.H.
        • Fairbairn A.F.
        • Jabeen S.
        • Perry E.K.
        Operational criteria for senile dementia of Lewy body type (SDLT).
        Psychol Med. 1992; 22: 911-922
        • Mendez M.F.
        • Mastri A.R.
        • Sung J.H.
        • Frey W.H.
        Clinically diagnosed Alzheimer’s disease.
        Alzheimer Dis Assoc Disord. 1992; 6: 35-43
        • Mirra S.S.
        • Heyman A.
        • McKeel D.
        • Sumi S.M.
        • Crain C.J.
        • Brownlee L.M.
        • et al.
        The consortium to establish a registry for Alzheimer’s disease (CERAD).
        Neurology. 1991; 41: 479-486
        • Moossy J.
        • Zubenko G.S.
        • Martinez A.J.
        • Rao G.R.
        Bilateral symmetry of morphologic lesions in Alzheimer’s disease.
        Arch Neurol. 1988; 45: 251-254
        • Morris J.C.
        • McKeel D.W.
        • Fulling K.
        • Torack R.M.
        • Berg L.
        Validation of clinical diagnostic criteria for Alzheimer’s disease.
        Ann Neurol. 1988; 24: 17-22
        • Mullan M.
        • Crawford F.
        • Axelman K.
        • Houlden H.
        • Lulius L.
        • Winblad B.
        • et al.
        A pathogenic mutation for probable Alzheimer’s disease in the APP gene at the N-terminus of β-amyloid.
        Nature Genet. 1992; 1: 345-347
        • Murrell J.
        • Farlow M.
        • Ghetti B.
        • Benson M.D.
        A mutation in the amyloid precursor protein associated with hereditary Alzheimer’s disease.
        Science. 1991; 254: 97-99
        • Myklebost O.
        • Rogne S.
        A physical map of the apolipoprotein gene cluster on human chromosome 19.
        Hum Genet. 1988; 78: 244-247
        • Nechiporuk A.
        • Fain P.
        • Kort E.
        • Nee L.E.
        • Frommelt E.
        • Polinsky R.J.
        • et al.
        Linkage of familial Alzheimer disease to chromosome 14 in 2 large early-onset pedigrees.
        Am J Med Genet. 1993; 48: 63-66
        • Okuizumi K.
        • Onodera O.
        • Tanaka H.
        • Kobayashi H.
        • Tsuji S.
        • Takahashi H.
        • et al.
        ApoE-epsilon 4 and early-onset Alzheimer’s.
        Nature Genet. 1994; 7: 10-11
        • Oppenheimer D.R.
        • Esiri M.M.
        Diseases of the basal ganglia, cerebellum and motor neurons. Parkinson’s disease (paralysis agitans).
        in: Adams J.H. Duchen L.W. Greenfield’s Neuropathology. 5th ed. Oxford University Press, New York1992: 991-997
        • Pericak-Vance M.A.
        • Bass M.P.
        • Yamaoka L.H.
        • Gaskell P.C.
        • Scott W.K.
        • Terwedow H.A.
        • et al.
        Complete genomic screen in late-onset familial Alzheimer disease. Evidence for a new locus on chromosome 12.
        JAMA. 1997; 278: 1237-1241
        • Perry E.K.
        • Haroutunian V.
        • Davis K.L.
        • Levy R.
        • Lantos P.
        • Eagger S.
        • et al.
        Neocortical cholinergic activities differentiate Lewy body dementia from classical Alzheimer’s disease.
        NeuroReport. 1994; 5: 747-749
        • Perry E.K.
        • Marshall E.
        • Perry R.H.
        • Irving D.
        • Smith C.J.
        • Blessed G.
        • et al.
        Cholinergic and dopaminergic activities in senile dementia of Lewy body type.
        Alz Dis Assoc Disord. 1990; 4: 87-95
        • Rebeck G.W.
        • Reiter J.S.
        • Strickland D.K.
        • Hyman B.T.
        Apolipoprotein E in sporadic Alzheimer’s disease.
        Neuron. 1993; 11: 575-580
        • Rogaev E.I.
        • Sherrington R.
        • Rogaeva E.A.
        • Levesque G.
        • Ikeda M.
        • Liang Y.
        • et al.
        Familial Alzheimer’s disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer’s disease type 3 gene.
        Nature. 1995; 376: 775-778
        • Rumble B.
        • Retallack R.
        • Hilbich C.
        • Simms G.
        • Multhaup G.
        • Martins R.
        • et al.
        Amyloid A4 protein and its precursor in Down’s syndrome and Alzheimer’s disease.
        N Engl J Med. 1989; 320: 1446-1452
        • Sahara N.
        • Yahagi Y.-I.
        • Takagi H.
        • Kondo T.
        • Okochi M.
        • Susami M.
        • et al.
        Identification and characterization of presenilin I-467, I-463, and I-374.
        FEBS Lett. 1996; 381: 7-11
        • Saitoh T.
        • Xia Y.
        • Chen X.
        • Masliah E.
        • Glaasko D.
        • Shults C.
        • et al.
        The CYP2D6B mutant allele is overrepresented in the Lewy body variant of Alzheimer’s disease.
        Ann Neurol. 1995; 37: 110-112
        • Saller C.F.
        • Salama A.I.
        Rapid automated analysis of biogenic amines and their metabolites using reversed-phase high performance liquid chromatography with electrochemical detections.
        J Chromatogr. 1984; 309: 287-298
        • Saunders A.M.
        • Strittmatter W.J.
        • Schmechel D.
        • St. George-Hyslop P.H.
        • Pericak-Vance M.A.
        • Joo S.H.
        • et al.
        Association of apolipoprotein E allele ϵ4 with late-onset familial and sporadic Alzheimer’s disease.
        Neurology. 1993; 43: 1467-1472
        • Schellenberg G.D.
        • Bird T.D.
        • Wijsman E.M.
        • Orr H.T.
        • Anderson L.
        • Nemens E.
        • et al.
        Genetic linkage evidence for a familial Alzheimer’s disease locus on chromosome 14.
        Science. 1992; 258: 668-671
        • Schmechel D.
        • Saunders A.
        • Strittmatter W.
        • Crain B.J.
        • Hulette C.M.
        • Joo S.H.
        • et al.
        Increased amyloid β-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease.
        Proc Natl Acad Sci USA. 1993; 90: 9649-9653
        • Sherrington R.
        • Govaev E.I.
        • Liang Y.
        • Rogaeva E.A.
        • Levesque G.
        • Ikdea M.
        • et al.
        Cloning of a gene bearing missense mutations in early-onset familial Alzheimer’s disease.
        Nature. 1995; 375: 754-760
        • Smith C.A.D.
        • Gough A.C.
        • Leigh P.N.
        • Summers B.A.
        • Harding A.E.
        • Maranganore D.M.
        • et al.
        Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson’s disease.
        Lancet. 1992; 339: 1375-1377
      3. Spatz H (1952): La maladie de Pick, les atrophies systématisées progressives et la sénescence cérébrale prématurée localisce. In: The Proceeding of the First International Congress of Neuropathology, vol. 2. Torino: Rosenberg, Sellier, pp 375–406.

        • St. George-Hyslop P.
        • Haines J.
        • Rogaev E.
        • Mortilla M.
        • Vaula G.
        • Pericak-Vance M.
        • et al.
        Genetic evidence for a novel familial Alzheimer’s disease locus on chromosome 14.
        Nature Genet. 1992; 2: 330-334
        • Strittmatter W.J.
        • Saunders A.M.
        • Schmechel D.
        • Pericak-Vance M.
        • Enghild J.
        • Salvesen G.S.
        • et al.
        Apolipoprotein E.
        Proc Natl Acad Sci USA. 1993; 90: 1977-1981
        • Tissot R.
        • Constantinidis J.
        • Richard J.
        La Maladie de Pick. Masson, Paris1975: 1-222
        • Ueki A.
        • Kawano M.
        • Namba Y.
        • Kawakami M.
        • Ikeda K.
        A high frequency of apolipoprotein E4 isoprotein in Japanese patients with late-onset nonfamilial Alzheimer’s disease.
        Neurosci Lett. 1993; 163: 166-168
        • van Broeckhoven C.
        • Backhovens H.
        • Cruts M.
        • de Winter G.
        • Bruyland M.
        • Cras P.
        • et al.
        Mapping of a gene predisposing to early-onset Alzheimer’s disease to chromosome 14q24.3.
        Nature Genet. 1992; 2: 335-339
        • van Duijn C.M.
        • de Knijff P.
        • Cruts M.
        • Wehner A.
        • Havekes L.M.
        • Hofman A.
        • et al.
        Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer’s disease.
        Nature Genet. 1994; 7: 74-78
        • Victoroff J.
        • Mack W.J.
        • Lyness S.A.
        • Chiu H.C.
        Multicenter clinicopathological correlation in dementia.
        Am J Psychiatry. 1995; 152: 1476-1484
        • Wade J.P.H.
        • Mirsen T.R.
        • Hachinski V.C.
        • Fisman M.
        • Lau C.
        • Merskey H.
        The clinical diagnosis of Alzheimer’s disease.
        Arch Neurol. 1987; 44: 24-29
        • Weiner M.F.
        • Risser R.C.
        • Cullum C.M.
        • Honig L.
        • White C.
        • Speciale S.
        • et al.
        Alzheimer’s disease and its Lewy body variant.
        Am J Psychiatry. 1996; 153: 1269-1273
        • Yoshizawa T.
        • Yamakawkobayashi K.
        • Komatsuzaki Y.
        • Arinami T.
        • Oguni E.
        • Mizusawa H.
        • et al.
        Dose-dependent association of apolipoprotein E allele epsilon 4 with late-onset, sporadic Alzheimer’s disease.
        Ann Neurol. 1994; 36: 656-659
        • Zubenko G.S.
        Hippocampal membrane alteration in Alzheimer’s disease.
        Brain Res. 1986; 385: 115-121
        • Zubenko G.S.
        Clinicopathological and neurochemical correlates of major depression and psychosis in primary dementia (in the IPA-sponsored Proceedings of the Consensus Conference on Behavioral Disturbances of Dementia).
        Int Psychogeriatrics. 1996; 8: 219-223
        • Zubenko G.S.
        Molecular neurobiology of Alzheimer’s disease (syndrome?).
        Harvard Rev Psychiatry. 1997; 5: 177-213
        • Zubenko G.S.
        • Cohen B.M.
        • Reynolds C.F.
        • Boller F.
        • Malinakova I.
        • Keefe N.
        Platelet membrane fluidity in Alzheimer’s disease and major depression.
        Am J Psychiatry. 1987; 144: 860-868
        • Zubenko G.S.
        • Henderson R.
        • Stiffler J.S.
        • Stabler S.
        • Rosen J.
        • Kaplan B.
        Association of APOE ϵ4 allele with clinical subtypes of late life depression.
        Biol Psychiatry. 1996; 40: 1008-1016
        • Zubenko G.S.
        • Hughes H.B.
        • Stiffler J.S.
        • Hurtt M.R.
        • Kaplan B.B.
        A genome survey for novel Alzheimer disease risk loci.
        Genomics. 1998; 50: 121-128
        • Zubenko G.S.
        • Moossy J.
        Major depression in primary dementia.
        Arch Neurol. 1988; 45: 1182-1186
        • Zubenko G.S.
        • Moossy J.
        • Hanin I.
        • Martinez A.J.
        • Rao G.R.
        • Kopp U.
        Bilateral symmetry of cholinergic deficits in Alzheimer’s disease.
        Arch Neurol. 1988; 45: 255-259
        • Zubenko G.S.
        • Moossy J.
        • Kopp U.
        Neurochemical correlates of major depression in primary dementia.
        Arch Neurol. 1990; 47: 209-214
        • Zubenko G.S.
        • Moossy J.
        • Martinez A.J.
        • Rao G.R.
        • Kopp U.
        • Hanin I.
        A brain regional analysis of morphologic and cholinergic abnormalities in Alzheimer’s disease.
        Arch Neurol. 1989; 46: 634-638
        • Zubenko G.S.
        • Stiffler J.S.
        • Hughes H.B.
        • Hurtt M.R.
        • Kaplan B.B.
        Initial results of a genome survey for novel Alzheimer’s disease risk genes.
        Am J Med Genet. 1998; 81: 98-107
        • Zubenko G.S.
        • Stiffler S.
        • Farr J.
        • Kopp U.
        • Hughes H.
        • Kaplan B.B.
        • Moossy J.
        Lack of variation in the nucleotide sequence corresponding to the transmembrane domain of the β-amyloid precursor protein in Alzheimer’s disease.
        Am J Med Genet. 1993; 48: 131-136
        • Zubenko G.S.
        • Stiffler S.
        • Stabler S.
        • Kopp U.
        • Hughes H.B.
        • Cohen B.M.
        • et al.
        Association of the apolipoprotein E ϵ4 allele with clinical subtypes of autopsy-confirmed Alzheimer’s disease.
        Am J Med Genet. 1994; 54: 199-205
        • Zubenko G.S.
        • Winwood E.
        • Jacobs B.
        • Teply I.
        • Stiffler J.S.
        • Hughes H.B.
        • et al.
        Prospective study of risk factors for Alzheimer’s disease.
        Am J Psychiatry. 1999; 156: 50-57
        • Zubenko G.S.
        • Wusylko M.
        • Boller F.
        • Cohen B.M.
        • Teply I.
        Family study of platelet membrane fluidity in Alzheimer’s disease.
        Science. 1987; 238: 539-542
        • Zweig R.M.
        • Ross C.A.
        • Hedreen J.C.
        • Steele C.
        • Cardiollo J.E.
        • Whitehouse P.J.
        • et al.
        The neuropathology of aminergic nuclei in Alzheimer’s disease.
        Ann Neurol. 1988; 24: 233-242